MedTrace Logo

ArcadiusXP L Post Market Clinical Follow-Up

NCT01895426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2017-03-22

No results posted yet for this study

Summary

The purpose of this study is to collect clinical and radiological mid-term (2 years) data on the ArcadiusXP L® lumbar stand-alone cage in a post-market clinical follow-up study (PMCF) limited to 32 patients.

Conditions

  • Degenerative Disc Disease

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Peter Douglas Klassen, MD (PY) · St. Bonifatius Hospital Lingen

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2017-01-31
Completion
2017-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01895426 on ClinicalTrials.gov